Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports.

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only. Codename:Pepe is merging AI with memecoin culture, ...

10x Genomics (NASDAQ:TXG – Get Free Report) had its price target reduced by investment analysts at Citigroup from $20.00 to $15.00 in a note issued to investors on Tuesday,Benzinga reports.

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

Approximatively 10,000 cells from each lung sample were loaded in a Chromium Controller or Chromium iX instrument (10x Genomics, Pleasanton, CA) and encapsuled with unique barcoded primers using the ...

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.

Investing.com -- Tesla (NASDAQ:TSLA) CEO Elon Musk said over the weekend that profits at the automaker could grow 1000% over the next 5 years if the company can execute. In response to a comment ...

LONDON--(BUSINESS WIRE)-- Cykel AI PLC (LSE: CYK) today announced an advancement in its artificial intelligence (AI) digital worker as Lucy, an AI-powered recruitment agent, demonstrated advanced ...

1 School of Computer and Information Engineering, Luoyang Institute of Science and Technology, Luoyang, China 2 State Key Laboratory of Bioelectronics; School of Biological Science & Medical ...

"By transforming questions about metabolism into a genomics challenge, we were able to draw a 'wiring map' of adult worm metabolism that revealed numerous novel insights." "The most exciting part ...